Ziad Sawi, MD
Anesthesiology · Las Vegas, NVNPI 1194725127
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Among anesthesiology clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$990
- Forte Bio-pharma LLC$740
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$578
- Medtronic$333
- Nevro Corp.$282
- Collegium Pharmaceutical, Inc.$267
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,551100%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 76 | $990 |
| Forte Bio-pharma LLC | 30 | $740 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 31 | $578 |
| Medtronic(2 entities) | 15 | $333 |
| Nevro Corp. | 2 | $282 |
| Collegium Pharmaceutical, Inc. | 14 | $267 |
| Daiichi Sankyo Inc. | 21 | $243 |
| Zyla Life Sciences, Inc. | 17 | $162 |
| IBSA Pharma Inc. | 7 | $153 |
| Abbott | 1 | $152 |
| Protega Pharmaceutials Inc | 6 | $123 |
| Tersera Therapeutics LLC | 3 | $97 |
| Xtant Medical Inc | 1 | $95 |
| Pfizer | 3 | $65 |
| Arbor Pharmaceuticals, Inc. | 5 | $60 |
| Amgen | 3 | $49 |
| AbbVie | 2 | $48 |
| Boston Scientific | 2 | $37 |
| Biodelivery Sciences International, Inc. | 2 | $27 |
| Si-bone, Inc. | 1 | $21 |
| Kaleo, Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,551 in reported general payments places this provider in the 95th percentile of 457 anesthesiology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 57 | $128,757 |
| ZtlidoLidocaine | 76 | $72,399 |
| LicartDiclofenac Epolamine | 47 | $52,237 |
| Diclofenac Sodium | 76 | $46,240 |
| HorizantGabapentin Enacarbil | 23 | $24,752 |
| RoxybondOxycodone Hcl | 11 | $21,375 |
| MovantikNaloxegol Oxalate | 49 | $19,584 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 496 | $14,788 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 380 | $13,028 |
| Lidocaine | 69 | $12,016 |
| LinzessLinaclotide | 18 | $9,899 |
| BelbucaBuprenorphine Hcl | 18 | $8,253 |
| Xtampza ErOxycodone Myristate | 11 | $7,437 |
| Oxycodone Hcl | 225 | $7,212 |
| Morphine Sulfate ErMorphine Sulfate | 139 | $5,285 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $578 | $128,75757 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $990 | $72,39976 claims |
| IBSA Pharma Inc.Licart | $153 | $52,23747 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $60 | $24,75223 claims |
| Protega Pharmaceutials IncRoxybond | $123 | $21,37511 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $267 | $15,68929 claims |
| AbbVieLinzess | $48 | $9,89918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 457 anesthesiology providers in Nevada.
Other anesthesiology in Las Vegas
- Edward LizanoLas Vegas$1.2M
- Steven EvansLas Vegas$52K
- Yi McWhorterLas Vegas$23K
- Khuram KhanLas Vegas$23K
- Stephanie DavidsonLas Vegas$13K
- Mauricio NinoLas Vegas$12K
- Christopher AhnLas Vegas$6K
- Balazs MakaiLas Vegas$6K
- Cherie ManyLas Vegas$4K
- Anderson HuLas Vegas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.